Dear Colleagues,

It is our pleasure to welcome you to the 22nd Annual Meeting – iMas Dubai 2024 – the International Minimal Access Surgery Conference at the Metropolitan Hotel Dubai on June 23, 2024.

This event signifies a transformative evolution from the annual ICAGE meeting, initiated in 2010 in the UAE by Prof. Dr. Rajesh Devassy and Prof. Dr. Rudy Leon De Wilde. A new chapter unfolds, offering a meticulously curated experience focusing on adenomyosis’s principles and best practices.

Our program features live surgery, state-of-the-art lectures, case discussions, and debates for a comprehensive exploration of the subject. Renowned keynote speakers, including Professors Attilio Di Spiezio Sardo, Ursula Catena, Rudy Leon De Wilde, Sven Becker, Mohamed Hamad  and others, highlight this subspecialty from Europe and around the world.

Innovative additions to iMaS Dubai include an online hands-on training session in hysteroscopic adenomyosis surgery by Dr. Rudi Campo and team, MIS Leuven, Belgium. Abstract submissions on adenomyosis are welcomed, with the winning entry earning a registration prize for the ESGE annual congress in Marseille, France (27th – 30th October 2024). The top three abstracts may also be presented at the ESGE congress and be featured in the PubMed Indexed Journal of the ESGE – Facts Views and Vision in Obstetrics and Gynecology (FVVO).

For young gynecologists, the conference offers educational courses by the ESGE ACADEMY and hands-on training workshops to optimize surgical skills. iMaS Dubai’s vast exhibition provides a platform for pharmaceutical and technology companies to showcase their latest products. Join us for a transformative and educational experience at iMaS Dubai 2024.


Prof. Dr. Rajesh Devassy                                          Prof. Dr. Rudy Leon De Wilde

Founder and Scientific Chair                                Founder and Scientific Chair


  • Comprehensive reviews of what really matters in contemporary adenomyosis treatment

  • Outstanding invited lecturers addressing themes of universal significance

  • An Artificial Intelligence Immersion experience, with remote navigation in non-surgical treatments

  • An “Envision and Creation Program,” designed to engage solution-focused Gynecologists in cooperative exercises to address some of the most pressing issues in adenomyosis treatment

  • An unprecedented, guided learning experience for health care executives interested in learning more about the present and future of adenomyosis treatment

  • We have created a “must-know,” content-rich program for the 2024 iMaS Dubai conference highlighting information of consequence and value at a crucial stage in the 163 YEARS history of adenomyosis, with fewer years of treatment and the world we contribute to